Related references
Note: Only part of the references are listed.The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression
Ingrid T. G. W. Bijsmans et al.
SCIENTIFIC REPORTS (2015)
VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis
Blythe C. Dillingham et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2015)
IL-6 Stimulates Intestinal Epithelial Proliferation and Repair after Injury
Kristine A. Kuhn et al.
PLOS ONE (2014)
VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid
Erica K. M. Reeves et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects
Christopher R. Heier et al.
EMBO MOLECULAR MEDICINE (2013)
Acute Cognitive and Behavioral Effects of Systemic Corticosteroids in Children Treated for Inflammatory Bowel Disease
Christine Mrakotsky et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2013)
How glucocorticoid receptors modulate the activity of other transcription factors: A scope beyond tethering
Dariusz Ratman et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
VBP15, a Glucocorticoid Analogue, Is Effective at Reducing Allergic Lung Inflammation in Mice
Jesse M. Damsker et al.
PLOS ONE (2013)
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Selective Glucocorticoid Receptor Agonists for the Treatment of Inflammatory Bowel Disease: Studies in Mice with Acute Trinitrobenzene Sulfonic Acid Colitis
Kerstin C. Reuter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Epithelial NF-kappa B Enhances Transmucosal Fluid Movement by Altering Tight Junction Protein Composition after T Cell Activation
Yueming Tang et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Targeting inflammation using selective glucocorticoid receptor modulators
Karolien De Bosscher et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Abrogation of Glucocorticoid Receptor Dimerization Correlates with Dissociated Glucocorticoid Behavior of Compound A
Steven Robertson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A robust in vitro screening assay to identify NF-κB inhibitors for inflammatory muscle diseases
Andreas R. Baudy et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
NF-κB in inflammatory bowel disease
I. Atreya et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Acute induction of human IL-8 production by intestinal epithelium triggers neutrophil infiltration without mucosal injury
T Kucharzik et al.
GUT (2005)
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
HM Reichardt et al.
EMBO JOURNAL (2001)
Review article: the limitations of corticosteroid therapy in Crohn's disease
PJ Rutgeerts
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Tissue cytokine and chemokine expression in inflammatory bowel disease
G McCormack et al.
INFLAMMATION RESEARCH (2001)
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
WA Faubion et al.
GASTROENTEROLOGY (2001)
RANTES potentiates antigen-specific mucosal immune responses
JW Lillard et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
